T. Rowe Price Associates’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
75,405
+4,239
| +6% | +$94.3K | ﹤0.01% | 1719 |
|
|
2025
Q1 | $1.69M | Buy |
71,166
+5,022
| +8% | +$119K | ﹤0.01% | 1690 |
|
|
2024
Q4 | $1.4M | Buy |
66,144
+5,327
| +9% | +$113K | ﹤0.01% | 1806 |
|
|
2024
Q3 | $1.96M | Sell |
60,817
-319,189
| -84% | -$10.3M | ﹤0.01% | 1645 |
|
|
2024
Q2 | $9.04M | Sell |
380,006
-648,650
| -63% | -$15.4M | ﹤0.01% | 1125 |
|
|
2024
Q1 | $30.7M | Sell |
1,028,656
-79,015
| -7% | -$2.36M | ﹤0.01% | 858 |
|
|
2023
Q4 | $35.4M | Sell |
1,107,671
-449,293
| -29% | -$14.4M | ﹤0.01% | 791 |
|
|
2023
Q3 | $45.5M | Buy |
1,556,964
+1,921
| +0.1% | +$56.2K | 0.01% | 708 |
|
|
2023
Q2 | $70M | Buy |
1,555,043
+620,680
| +66% | +$27.9M | 0.01% | 608 |
|
|
2023
Q1 | $32.2M | Buy |
934,363
+458,864
| +97% | +$15.8M | ﹤0.01% | 804 |
|
|
2022
Q4 | $13.2M | Sell |
475,499
-164,777
| -26% | -$4.59M | ﹤0.01% | 1004 |
|
|
2022
Q3 | $15M | Sell |
640,276
-1,549,488
| -71% | -$36.3M | ﹤0.01% | 988 |
|
|
2022
Q2 | $63.3M | Sell |
2,189,764
-472,157
| -18% | -$13.7M | 0.01% | 806 |
|
|
2022
Q1 | $147M | Sell |
2,661,921
-148,159
| -5% | -$8.16M | 0.01% | 623 |
|
|
2021
Q4 | $150M | Buy |
2,810,080
+284,644
| +11% | +$15.2M | 0.01% | 640 |
|
|
2021
Q3 | $107M | Sell |
2,525,436
-160,058
| -6% | -$6.78M | 0.01% | 751 |
|
|
2021
Q2 | $179M | Sell |
2,685,494
-38,503
| -1% | -$2.57M | 0.02% | 595 |
|
|
2021
Q1 | $121M | Buy |
2,723,997
+2,716,573
| +36,592% | +$120M | 0.01% | 711 |
|
|
2020
Q4 | $215K | Buy |
+7,424
| New | +$215K | ﹤0.01% | 2534 |
|